NCT02660853View on ClinicalTrials.gov

Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Asthma
Interventions
DIAGNOSTIC_TEST

FEV1

Participants have FEV1 test

Trial Locations (1)

SW3 6NP

Biomedical research Unit, Royal Brompton Hospital, Sydney Street, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT02660853 - Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers | Biotech Hunter | Biotech Hunter